Prednisolone Sodium Phosphate

ApprovedSmall molecule

Prednisolone Sodium Phosphate is one of 44 small molecule programs targeting Otitis Media With Effusion. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Otitis Media With EffusionActive, not recruiting

WheezingActive, not recruiting

AsthmaActive, not recruiting

Otitis Media With EffusionPhase 1

Active, not recruiting

WheezingApproved

Active, not recruiting

AsthmaApproved

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Prednisolone Sodium Phosphate

UUniversity of Oulu

Approved

1 2

Veramyst

GSK

Preclinical

46 3

Xolair

Roche

Preclinical

25 4

Cinqair

Teva

Preclinical

13 5

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 6

Atrovent

Boehringer Ingelheim

Preclinical

5 7

Arcoxia

Symbicort

6 9

Aciphex

Akero Therapeutics

Preclinical

2 10

Atrovent

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Post-ApprovalRecruiting

Wheezing

NCT05444699

Clinical

Trials by Indication[1]

Wheezing1 trial

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age

Recruiting·UUniversity of Oulu·Phase 4·NCT05444699·210 enrolled

Asthma1 trial

Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children

Completed·UUniversity College Dublin·Phase 4·NCT03698630·250 enrolled

Otitis Media With Effusion1 trial

The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study

Unknown status·MMuteea Mubark Salmen Bakuwiri·Phase 1·NCT03491098·60 enrolled

Treatment1 trial

Parasitic Ulcer Treatment Trial Pilot

Unknown status·UUniversity of California, San Francisco·Phase 2·NCT03484507·49 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Prednisolone Sodium Phosphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prednisolone Sodium Phosphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prednisolone Sodium Phosphate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Oulu company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Oulu

Prednisolone Sodium Phosphate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Wheezing1 trial

Asthma1 trial

Otitis Media With Effusion1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News